Lisinopril Tablets Recalled for Embedded Metal Contamination
Lupin Pharmaceuticals is recalling Lisinopril 10 mg tablets due to discovery of a metal piece embedded in one tablet. Affected lot Q201182 was distributed nationwide to wholesalers.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: FDA Class II drug recall with a physical contaminant (metal piece) embedded in a tablet, posing a risk of harm if ingested. No illnesses or injuries have been reported to date, but the presence of a foreign object in medication represents a legitimate safety hazard.
Plain-English summary
Lupin Pharmaceuticals Inc. is recalling Lisinopril Tablets USP, 10 mg, in 1000-count bottles due to discovery of foreign material (a metal piece) embedded in one tablet.
A metal piece was found embedded within a single tablet in the affected lot, which poses a potential safety risk to consumers if the contaminated tablet is taken.
The recall affects 11,802 bottles of 1000-count Lisinopril tablets (lot # Q201182, expiration date March 2024). The affected product was distributed to major pharmaceutical distributors and wholesalers nationwide. NDC 68180-980-03.
Consumers taking Lisinopril from this lot should contact their pharmacist or healthcare provider. Do not consume tablets from this lot. Return the product to the pharmacy where it was obtained, or contact Lupin Pharmaceuticals for instructions on returning the product.
The recalled product
- Product
- LISINOPRIL (LISINOPRIL)
- Brand
- LISINOPRIL
- Manufacturer
- Lupin Pharmaceuticals Inc.
- Category
- Drug — Prescription Drug
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot # Q201182
- exp. date March 2024
UPCs (3)
- 0368180513018
- 0368180512028
- 0368180513032
Distribution
Distributed nationwide across the United States.
Related recalls
Same brand · LISINOPRIL
- HighLisinopril 10 mg Tablets Recalled for Metal Fragment Contamination
FDA (Drugs) · 2024-11-27
- HighLupin Recalls Lisinopril Tablets Due to Foreign Tablet Presence
FDA (Drugs) · 2020-08-05
- HighLupin Recalls Lisinopril 5 mg Tablets Due to Product Mix-Up
FDA (Drugs) · 2020-06-17
- ModerateLupin Recalls Lisinopril Tablets Due to Foreign Tablet Mix-Up
FDA (Drugs) · 2020-04-08
- SevereLupin Recalls Lisinopril Tablets Due to Metal Contaminant
FDA (Drugs) · 2018-08-22
Same manufacturer · Lupin Pharmaceuticals Inc.
See all →- ModerateLupin Recalls Clobetasol Propionate Cream for Content Uniformity Failures
FDA (Drugs) · 2026-09-02
- SevereGlucagon Emergency Kit Recalled for Manufacturing Process Deviation
FDA (Drugs) · 2026-07-08
- HighPrednisolone Acetate Ophthalmic Suspension Recalled for Foreign Substance
FDA (Drugs) · 2026-07-08
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27
- ModerateGanirelix acetate injection recalled after failing an impurity specification
FDA (Drugs) · 2025-12-17
Same hazard · metal contamination
See all →- HighRose and Shore Margarita Thin Crust Pizza Recalled for Metal Contamination
FDA (Food) · 2026-04-01
- HighWhite Oak Pastures Ground Beef Alerted for Possible Metal Contamination
USDA FSIS · 2026-03-23
- HighTestosterone 200 mg pellets recalled over potential metal particulate matter
FDA (Drugs) · 2025-11-05
- HighTestosterone 87.5 mg pellets recalled over potential metal particulate matter
FDA (Drugs) · 2025-11-05
- HighTestosterone and triamcinolone pellets recalled over potential metal particulate matter
FDA (Drugs) · 2025-11-05